NEWTON,
Mass., Sept. 3, 2024 /PRNewswire/ --
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a
commercial-stage pharmaceutical company pioneering novel cancer
therapies, today announced that the Company's senior
management team will participate in the following investor
conferences in September:
H.C. Wainwright 26th Annual
Global Investment Conference
Format: Podium
presentation
Date: Tuesday, September 10, 2024
Time: 9:00 a.m. ET
Baird 2024 Global Healthcare
Conference
Format: Fireside chat
Date: Wednesday, September 11, 2024
Time: 10:50 a.m. ET
A live webcast of these events, along with accompanying
slides, can be accessed under "Events & Presentations" in the
Investor section of the Company's website,
http://investors.karyopharm.com/events-presentations,
and will be available for replay following the event.
About Karyopharm
Therapeutics
Karyopharm Therapeutics Inc. (Nasdaq: KPTI)
is a commercial-stage pharmaceutical company whose dedication to
pioneering novel cancer therapies is fueled by a belief in the
extraordinary strength and courage of patients with cancer. Since
its founding, Karyopharm has been an industry leader in oral
compounds that address nuclear export dysregulation, a fundamental
mechanism of oncogenesis. Karyopharm's lead compound and
firstinclass, oral exportin 1 (XPO1) inhibitor, XPOVIO®
(selinexor), is approved in the U.S. and marketed by the Company in
three oncology indications. It has also received regulatory
approvals in various indications in a growing number of exU.S.
territories and countries, including Europe and the United Kingdom (as NEXPOVIO®) and China. Karyopharm has a focused pipeline
targeting indications in multiple high unmet need cancers,
including in multiple myeloma, endometrial cancer, myelofibrosis,
and diffuse large B-cell lymphoma (DLBCL). For more information
about our people, science and pipeline, please visit
www.karyopharm.com, and follow us on LinkedIn
and on X at @Karyopharm.
XPOVIO® and NEXPOVIO® are registered
trademarks of Karyopharm Therapeutics Inc. Any other trademarks
referred to in this release are the property of their respective
owners.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/karyopharm-to-participate-at-upcoming-investor-conferences-302235059.html
SOURCE Karyopharm Therapeutics Inc.